Wolverine Asset Management LLC Ascendis Pharma A/S Transaction History
Wolverine Asset Management LLC
- $4.35 Billion
- Q3 2024
A detailed history of Wolverine Asset Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Wolverine Asset Management LLC holds 1,700 shares of ASND stock, worth $216,835. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,700Holding current value
$216,835% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ASND
# of Institutions
241Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.24 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$655 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$636 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$563 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$534 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.12B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...